Status:
ENROLLING_BY_INVITATION
ADL+2.0: Intervention for Prevention of Cognitive Decline in Community-dwelling Older Adults
Lead Sponsor:
Tan Tock Seng Hospital
Collaborating Sponsors:
Nanyang Technological University
Geriatric Education and Research Institute
Conditions:
Cognitive Decline
Eligibility:
All Genders
60-99 years
Phase:
NA
Brief Summary
Singapore's rising dementia incidence with an ageing population presents an urgent need for effective interventions that delay or prevent cognitive decline. While multi-domain intervention studies for...
Detailed Description
An estimated one in 10 people aged 60 and above in Singapore suffers from dementia. With increasing life expectancy and a rapidly ageing population, the number of persons living with dementia is expec...
Eligibility Criteria
Inclusion
- ≥60 Years old
- Participants from partnering Active Ageing Centres (AACs) across Singapore
- Subjective memory complaint (AD8 ≥ 2)
- Independent in activities of daily living (ADL)
- Able to speak English and/or Mandarin
- Comfortable with using smartphones
- Not currently enrolled in a formal cognitive training program.
Exclusion
- Known dementia or suspected dementia after initial screening
- Significant medical illnesses
Key Trial Info
Start Date :
May 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT07141160
Start Date
May 8 2025
End Date
December 31 2029
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tan Tock Seng Hospital
Singapore, Singapore